Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.

Literature DB >> 25741005

Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.

Ming Yuan¹, Wensheng Zhang², Jun Wang¹, Chadwan Al Yaghchi¹, Jahangir Ahmed¹, Louisa Chard¹, Nick R Lemoine³, Yaohe Wang³.

Abstract

Vaccinia virus (VACV) continues to be used in immunotherapy for the prevention of infectious diseases and treatment of cancer since its use for the eradication of smallpox. However, the current method of editing the VACV genome is not efficient. Here, we demonstrate that the CRISPR-Cas9 system can be used to edit the VACV genome rapidly and efficiently. Additionally, a set of 8,964 computationally designed unique guide RNAs (gRNAs) targeting all VACV genes will be valuable for the study of VACV gene functions.

Entities: Chemical

Mesh：

Year: 2015 PMID： 25741005 PMCID： PMC4403460 DOI： 10.1128/JVI.00339-15

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

26 in total

1. The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility.

Authors: Ina Weisswange; Timothy P Newsome; Sibylle Schleich; Michael Way
Journal: Nature Date: 2009-03-05 Impact factor: 49.962

Review 2. CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors: John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal: Trends Biochem Sci Date: 2009-07-29 Impact factor: 13.807

3. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

Authors: Caroline J Breitbach; James Burke; Derek Jonker; Joe Stephenson; Andrew R Haas; Laura Q M Chow; Jorge Nieva; Tae-Ho Hwang; Anne Moon; Richard Patt; Adina Pelusio; Fabrice Le Boeuf; Joe Burns; Laura Evgin; Naomi De Silva; Sara Cvancic; Terri Robertson; Ji-Eun Je; Yeon-Sook Lee; Kelley Parato; Jean-Simon Diallo; Aaron Fenster; Manijeh Daneshmand; John C Bell; David H Kirn
Journal: Nature Date: 2011-08-31 Impact factor: 49.962

4. Transient dominant selection of recombinant vaccinia viruses.

Authors: F G Falkner; B Moss
Journal: J Virol Date: 1990-06 Impact factor: 5.103

5. Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain.

Authors: B Billings; S A Smith; Z Zhang; D K Lahiri; G J Kotwal
Journal: Ann N Y Acad Sci Date: 2004-12 Impact factor: 5.691

6. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors: Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal: Science Date: 2012-06-28 Impact factor: 47.728

7. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors: M Mackett; G L Smith; B Moss
Journal: J Virol Date: 1984-03 Impact factor: 5.103

8. Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors: Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal: Science Date: 2008-08-15 Impact factor: 47.728

9. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.

Authors: Julianne Stack; Ismar R Haga; Martina Schröder; Nathan W Bartlett; Geraldine Maloney; Patrick C Reading; Katherine A Fitzgerald; Geoffrey L Smith; Andrew G Bowie
Journal: J Exp Med Date: 2005-03-14 Impact factor: 14.307

10. Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer.

Authors: J R Tysome; A Briat; G Alusi; F Cao; D Gao; J Yu; P Wang; S Yang; Z Dong; S Wang; L Deng; J Francis; T Timiryasova; I Fodor; N R Lemoine; Y Wang
Journal: Gene Ther Date: 2009-07-09 Impact factor: 5.250

45 in total

Review 1. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.

Authors: Lulia Koujah; Deepak Shukla; Afsar R Naqvi
Journal: Semin Cell Dev Biol Date: 2019-04-08 Impact factor: 7.727

2. Extracellular Vesicles and Their Use as Vehicles of Immunogens.

Authors: Chiara Chiozzini; Barbara Ridolfi; Maurizio Federico
Journal: Methods Mol Biol Date: 2022

3. Identification of essential and non-essential genes in Ambystoma tigrinum virus.

Authors: Mariah M Aron; Alexander G Allen; Mathew Kromer; Hector Galvez; Brianna Vigil; James K Jancovich
Journal: Virus Res Date: 2016-03-26 Impact factor: 3.303

4. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.

Authors: Craig J Bierle; Kaitlyn M Anderholm; Jian Ben Wang; Michael A McVoy; Mark R Schleiss
Journal: J Virol Date: 2016-07-11 Impact factor: 5.103

5. A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors.

Authors: Ming Yuan; Pengju Wang; Louisa S Chard; Nicholas R Lemoine; Yaohe Wang
Journal: J Vis Exp Date: 2016-10-30 Impact factor: 1.355

6. MAVERICC: Marker-free Vaccinia Virus Engineering of Recombinants through in vitro CRISPR/Cas9 Cleavage.

Authors: Ethan Laudermilch; Kartik Chandran
Journal: J Mol Biol Date: 2021-02-24 Impact factor: 5.469

Review 7. Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Authors: Man Teng; Yongxiu Yao; Venugopal Nair; Jun Luo
Journal: Viruses Date: 2021-04-28 Impact factor: 5.048